Work

Patient-Specific Stem Cells and Cardiovascular Drug Discovery

Year: 2013

Type: article

Source: JAMA

DOI: 10.1001/jama.2013.282409

Authors: Nicholas M. Mordwinkin, Andrew S. Lee, Joseph C. Wu

Institutions: Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cardiovascular Institute, Stanford University

Language: English

Topic: Pluripotent Stem Cells Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, National Heart, Lung, and Blood Institute, National Institute of Biomedical Imaging and Bioengineering

Awards: iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease, Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford, Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling

OpenAlex ID: W2059116299

FWCI: 2.762

Cites: 9

Cited by: 41

Related to: 10